X

Health Care

Vertex Pharmaceuticals Inc (VRTX): Q4 2019 Earnings Snapshot

--  Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported earnings of $1.70 per share in the fourth-quarter 2019, vs. $1.20 per share expected.  --…

Amgen’s (AMGN) Q4 results beat estimates

Amgen Inc. (NASDAQ: AMGN) topped revenue and earnings estimates for the fourth quarter of 2019. However, shares fell 2.7% in…

Biogen (NASDAQ: BIIB): Q4 2019 Earnings Snapshot

-- Biogen Inc. (NASDAQ: BIIB) reported its fourth-quarter 2019 adjusted earnings of $8.34 per share versus $8.02 per share expected.…

Eli Lilly (NYSE: LLY): Q4 2019 Earnings Snapshot

-- Eli Lilly and Company (NYSE: LLY) reported its fourth-quarter 2019 adjusted earnings of $1.73 per share versus $1.52 per…

Alexion Pharmaceuticals, Inc. (ALXN): Earnings Snapshot

--  Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported earnings of $2.71 per share in the fourth-quarter 2019, vs. $2.60 per share…

Anthem Inc (ANTM): Q4 2019 Earnings Snapshot

--  Anthem, Inc. (NYSE: ANTM) reported earnings of $3.88 per share in the fourth-quarter 2019, in line with the Street…

Stryker (SYK): Q4 2019 Earnings Snapshot

-- Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. -- Total…

Pfizer beats Q4 revenue estimates; earnings miss expectations

Pfizer Inc. (NYSE: PFE) topped revenue expectations for the fourth quarter of 2019 while earnings missed the mark. Shares fell…

Key factors to note when Pfizer (PFE) reports Q4 earnings results

Pfizer Inc. (NYSE: PFE) is scheduled to report fourth quarter 2019 earnings results on Tuesday, January 28, before the market…

Abbott Laboratories (ABT) reports in-line earnings for Q4; guides FY20

Abbott Laboratories (NYSE: ABT) reported a marked increase in fourth-quarter earnings as the drugmaker's strong product portfolio boosted sales in…

Johnson & Johnson (JNJ) beats Q4 earnings estimates, misses on revenue

Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations.…

PetMed Express (NASDAQ: PETS) Q3 2019 Earnings Call Transcript

PetMed Express Inc (PETS) Q3 2019 Earnings Conference Call Final Transcript Corporate Participants Bruce S. Rosenbloom Chief Financial Officer and Treasurer…

PetMed (PETS) Q3 earnings drop but beat Street view; sales miss

Earnings of PetMed Express Inc. (NASDAQ: PETS) decreased in the third quarter even as net sales remained unchanged. The bottom…

PetMed Express (PETS) likely to report weak Q3 earnings on Jan 21

PetMed Express Inc. (NASDAQ: PETS) is slated to report its third-quarter 2020 earnings results on Tuesday, January 21, before the…

UnitedHealth Group beats Q4 earnings estimates; revenues match expectations

UnitedHealth Group (NYSE: UNH) reported better-than-expected earnings for the fourth quarter of 2019 while revenues matched estimates. Shares were down…

Boston Scientific (BSX) stock drops on weak Q4 preliminary revenue

Boston Scientific Corporation (NYSE: BSX) stock dropped over 6% on Tuesday after its preliminary fourth-quarter report. The shares have fallen…

UnitedHealth (UNH) Q4 earnings preview: Get ready for another good show

UnitedHealth Group (NYSE: UNH) has been expanding its market value steadily, especially after reporting stronger-than-expected third-quarter results a few months…

Walgreens (WBA) Q1 profit drops 25%, misses estimates

Walgreens Boots Alliance Inc. (NASDAQ: WBA) reported a 25% drop in earnings for the first quarter of 2020 due to…

New hope for investors as Amarin (AMRN) sees a promising year ahead

Though Amarin Corporation (NASDAQ: AMRN) has been showing signs of recovery since last year, after staying low for several years,…

SmileDirectClub (SDC) stock rebounds amid growth prospects concern

SmileDirectClub Inc. (NASDAQ: SDC) stock rebounded over 26% in the past month on bullish outlook after the launch of a…

AngioDynamics (ANGO): Q2 2020 Earnings Snapshot

-- AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected. -- Net sales remained…